About X.J. Meng’s Research
Meng’s laboratory studies emerging, re-emerging and zoonotic viruses that are of human and veterinary public health importance. Meng lab’s achievements include the discovery of swine and avian hepatitis E viruses and invention of the first U.S. Department of Agriculture fully-licensed commercial vaccine against porcine circovirus type 2.
Meng has authored or co-authored more than 300 peer-reviewed articles and book chapters. According to Google Scholar, these have been cited more than 20,000 times. Meng has been awarded more than 46 research grants as a principal investigator totaling more than $17 million, and he is also a co-investigator or collaborator on more than 57 other awarded grants of more than $28 million. Meng is a named inventor on 21 awarded and 17 pending U.S. patents, as well as 40 awarded foreign patents on various virus vaccines and diagnostics.
- Hepatitis E virus (HEV)
- Porcine Circovirus (PCV)
- Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
- Torque Teno Sus Virus (TTSuV)
- Porcine Epidemic Diarrhea Virus (PEDV)
More details about these areas of research can be found on the Research Interests page.